0000950170-24-043690.txt : 20240411 0000950170-24-043690.hdr.sgml : 20240411 20240411160509 ACCESSION NUMBER: 0000950170-24-043690 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240410 FILED AS OF DATE: 20240411 DATE AS OF CHANGE: 20240411 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Finn Jonathan CENTRAL INDEX KEY: 0001981595 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35610 FILM NUMBER: 24838519 MAIL ADDRESS: STREET 1: C/O VANTAGE CONSULTING GROUP, INC. STREET 2: 3500 PACIFIC AVENUE CITY: VIRGINIA BEACH STATE: VA ZIP: 23451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ATOSSA THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001488039 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 264753208 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 107 SPRING STREET CITY: SEATTLE STATE: WA ZIP: 98104 BUSINESS PHONE: 206.588.0256 MAIL ADDRESS: STREET 1: 107 SPRING STREET CITY: SEATTLE STATE: WA ZIP: 98104 FORMER COMPANY: FORMER CONFORMED NAME: ATOSSA GENETICS INC DATE OF NAME CHANGE: 20100325 4 1 ownership.xml 4 X0508 4 2024-04-10 0001488039 ATOSSA THERAPEUTICS, INC. ATOS 0001981595 Finn Jonathan C/O 107 SPRING STREET SEATTLE WA 98104 true false false false false Common Stock 2024-04-10 4 P false 25000 1.77 A 25000 D The price reported represents the weighted average purchase price per share. The shares were purchased in multiple transactions at prices ranging from $1.74 to $1.78. Upon request from the staff of the U.S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer, The Reporting Person will provide full information regarding the number of shares purchased at each separate price. /s/ Heather Rees, as attorney-in-fact for Jonathan Finn 2024-04-11